You are here: Industry Insights > Chantix

News List

Pfizer Expands Recall to Twelve Lots of Chantix Tablets americanpharmaceuticalreview
July 22, 2021
Pfizer is voluntarily recalling two lots of Chantix 0.5mg Tablets, two lots of Chantix 1 mg Tablets, and eight lots of a Chantix kit of 0.5mg/1 mg Tablets to the patient (consumer/user) level due to the presence of a nitrosamine, N-nitroso-varenicline ...
Pfizer Expands its Voluntary Recall of Chantix americanpharmaceuticalreview
July 21, 2021
Pfizer expanded its voluntary recall of varenicline (Chantix) to 12 consumer-level lots. Pfizer is recalling these lots due to the presence of N-nitroso-varenicline above the company’s acceptable limit for this impurity.
FDA Update on Chantix with Nitrosamine Impurity americanpharmaceuticalreview
July 20, 2021
To ensure patient access to Chantix (varenicline), the FDA will not object to certain manufacturers temporarily distributing varenicline tablets containing N-nitroso-varenicline above FDA’s acceptable intake limit of 37 ng per day but below the ...
Recall of Chantix Due to Impurity americanpharmaceuticalreview
July 05, 2021
FDA is alerting patients and health care professionals to Pfizer’s voluntary recall of nine lots of the smoking cessation drug, varenicline (brand name Chantix), to the warehouse level.
Pfizer halts distribution of anti-smoking drug after finding carcinogen expresspharma
June 28, 2021
The US drug regulator has, in the past, reached out to companies whose drugs had N-nitrosodimethylamine (NDMA) over accepted levels.
Not ready to quit smoking cold turkey? Pfizer offers 'slow turkey' campaign for Chantix fiercepharma
February 24, 2019
Pfizer is introducing a new way to quit smoking.
Price of Pfizer's smoking-cessation drug Chantix doubles in just 5 years fiercepharma
June 27, 2018
Pfizer’s smoking-cessation drug Chantix nudged closer to blockbuster status last year, bringing in $997 million in sales—up 18% from 2016.